Who are the newly appointed independent directors?

The newly appointed independent directors are Zhao Ying-Cheng, Zhang Yi-Fang, Zhang Zhi-Gang, and Di Shi-Jie.

What are the professional backgrounds of the new independent directors?

Zhao Ying-Cheng is listed as a former TSMC Plant Manager. Zhang Yi-Fang is the Vice President of Mackay Taitung Branch. Zhang Zhi-Gang is the CEO of Zhongen Biomedical. Di Shi-Jie is an Associate Professor at the University of Hong Kong.

What was the previous term for the independent directors?

The previous term was from September 26, 2023, to June 11, 2026.

Polaris Pharmaceuticals-KY Announces Audit Committee Member Changes

Q: What was the reason for the change in the Audit Committee members?

The change was due to the full re-election of directors, including independent directors, at the company's 2026 Annual General Meeting.

Published May 16, 2026 12:57 PM ・ Updated Jun 13, 2026 11:57 PM ・ 4 min read ・ Source: PR Times

Polaris Pharmaceuticals-KY (6550) announced changes to its Audit Committee members on May 15, 115 (2026). The changes are due to the full re-election of directors, including independent directors, at the company's 2026 Annual General Meeting. The previous term for the independent directors was from September 26, 112 (2023) to June 11, 115 (2026). Zhao Ying-Cheng, an independent director, has been re-appointed. New independent directors appointed are Zhang Yi-Fang (Vice President of Mackay Taitung Branch), Zhang Zhi-Gang (CEO of Zhongen Biomedical), and Di Shi-Jie (Associate Professor at the University of Hong Kong). Zhao Ying-Cheng's brief biography is listed as former TSMC Plant Manager.

Announcement Date: May 16, 115 (2026) Statement Date: May 15, 115 (2026) Statement Time: 21:16:27 Company Code: 6550 Company Name: Polaris Pharmaceuticals-KY Subject: Announcement of the list of members of the company's Audit Committee Compliance Clause: Clause 6 Date of Fact Occurrence: May 15, 115 (2026) Explanation: 1. Date of Change: 115/05/15 2. Functional Committee Name: Audit Committee 3. Former Members: Independent Director Zhao Ying-Cheng Independent Director Wei Zong-De Independent Director Wen (Ri Min) Guo Lan Independent Director Zeng Guo-Hua 4. Brief Biographies of Former Members: Independent Director Zhao Ying-Cheng / Independent Director of this company Independent Director Wei Zong-De / Independent Director of this company Independent Director Wen (Ri Min) Guo Lan / Independent Director of this company Independent Director Zeng Guo-Hua / Independent Director of this company 5. New Members: Independent Director Zhao Ying-Cheng Independent Director Zhang Yi-Fang Independent Director Zhang Zhi-Gang Independent Director Di Shi-Jie 6. Brief Biographies of New Members: Independent Director Zhao Ying-Cheng / Former TSMC Plant Manager Independent Director Zhang Yi-Fang / Vice President of Mackay Taitung Branch Independent Director Zhang Zhi-Gang / CEO of Zhongen Biomedical Independent Director Di Shi-Jie / Associate Professor at the University of Hong Kong 7. Change Details (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration 8. Reason for Change: Full re-election of directors (including independent directors) at the 2026 Annual General Meeting. 9. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/09/26 ~ 115/06/11 10. Effective Date of New Appointment: 115/05/15 11. Other Matters to be Notified: None

FACT BOX

Source: PR Times
Category: Corporate Governance

Polaris Pharmaceuticals-KY Announces Audit Committee Member Changes

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY